FdaApplication
ANDA 209983
Identifiers
- fda_app_no: ANDA209983
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2023-12-26 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POSACONAZOLE | POSACONAZOLE | 300MG/16.7ML (18MG/ML) | SOLUTION;INTRAVENOUS |
1 product